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The clathrin adaptors AP-1 and AP-2 bind cargo proteins via two types of motifs: tyrosine-based Yxx and dileucine-
based [DE]XXXL[LI]. Although it is well established that Yxx motifs bind to the  subunits of AP-1 or AP-2, dileucine
motifs have been reported to bind to either the  or  subunits of these adaptors as well as the /1 hemicomplex of AP-1.
To clarify this controversy, the various subunits of AP-1 and AP-2 were expressed individually and in hemicomplex form
in insect cells, and they were used in glutathione S-transferase pull-down assays to determine their binding properties.
We report that the /1 or /2 hemicomplexes bound the dileucine-based motifs of several proteins quite strongly,
whereas binding by the 1/1 and 2/2 hemicomplexes, and the individual  or  subunits, was extremely weak or
undetectable. The /1 and /2 hemicomplexes displayed substantial differences in their preference for particular
dileucine-based motifs. Most strikingly, an aspartate at position 4 compromised binding to the /1 hemicomplex,
whereas minimally affecting binding to /2. There was an excellent correlation between binding to the /2 hemicom-
plex and in vivo internalization mediated by the dileucine-based sorting signals. These findings provide new insights into
the trafficking mechanisms of D/EXXXL[LI]-mediated sorting signals.
INTRODUCTION
The plasma membrane and the trans-Golgi network (TGN)
represent key sorting sites for many transmembrane pro-
teins, mediated via sorting signals present in the cytosolic
domain of these proteins. One mechanism for sorting in-
volves the assembly of clathrin-coated vesicles at the sorting
site that subsequently pinch off and uncoat before fusing
with their target membranes, thereby delivering cargo to
their appropriate destinations. The heterotetrameric adaptor
proteins AP-1 and AP-2 are major components of clathrin-
coated vesicles originating at the TGN and plasma mem-
brane, respectively. Each of these adaptors is composed of
two large subunits ( and 1 for AP-1,  and 2 for AP-2), a
medium subunit (1 and 2), and a small subunit (1 and
2) (see Figure 1A for a schematic of the subunit organiza-
tion of AP-1 and AP-2). The interactions of AP-1 and AP-2
with transmembrane proteins occur mainly via two types of
sorting signals: tyrosine-based YXX (-bulky hydrophobic)
and dileucine-based [DE]XXXL[LI] motifs (Bonifacino and
Traub, 2003). Biochemical and structural studies have un-
equivocally determined that YXX motifs engage the  sub-
units of adaptor proteins (Ohno et al., 1995; Owen and
Evans, 1998). However, the binding site for dileucine-based
motifs has been the subject of debate. It has been reported by
various groups that this motif binds to the  subunits of
AP-1 and AP-2 (Rapoport et al., 1998; Greenberg et al., 1998;
Geyer et al., 2002; Schmidt et al., 2006), to the  subunits of
AP-1 and AP-2 (Rodionov and Bakke, 1998; Hofmann et al.,
1999; Craig et al., 2000; Rodionov et al., 2002; Hinners et al.,
2003), and, more recently, to the /1 hemicomplex of AP-1
(Janvier et al., 2003; Coleman et al., 2005, 2006; Theos et al.,
2005). The latter studies involved the use of the yeast three-
hybrid technique. However, this assay failed to detect an
interaction between dileucine motifs and the /2 hemi-
complex of AP-2 (Janvier et al., 2003; Coleman et al., 2005).
Because an understanding of how dileucine-based motifs
bind AP-1 and AP-2 is essential to explain the sorting pro-
cess at the molecular level, we sought to address the issue in
a more direct manner. To do so, we have expressed each of
the subunits of AP-1 and AP-2 individually as well as the
/1, 1/1, /2, and 2/2 hemicomplexes in Sf9 insect
cells. These recombinant proteins were then used in gluta-
thione S-transferase (GST) pull-down assays involving var-
ious dileucine-based motifs. Here, we report that the /1
and /2 hemicomplexes bind dileucine signals strongly,
whereas binding to the 1/1 and the 2/2 hemicom-
plexes, or the isolated  or  subunits, is extremely weak or
undetectable by comparison. However, the /1 and /2
hemicomplexes exhibit substantial differences in their pref-
erence for particular dileucine-based motifs. In addition, we
present evidence for a strong correlation between AP-2 /2
hemicomplex binding to various dileucine sequences and
internalization mediated by these sequences.
MATERIALS AND METHODS
DNA Constructs, Plasmids, and Antibodies
Full-length cDNA clones encoding the  subunit of human AP-1; the 1, 1,
and 1 subunits of mouse AP-1; and the (C), 2, 2, and 2 subunits of
human AP-2 were purchased from American Type Culture Collection (Man-
assas, VA). The cDNAs were amplified by polymerase chain reaction (PCR)
and inserted into the vector pFastBac-Dual (Invitrogen, Carlsbad, CA), either
individually or as /1, 1/1, /2, and 2/2 bicisctronic coexpression
constructs (Figure 1B). In addition, the / and 1/2 cDNAs had sequences
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appended at their 3 ends that encoded peptides for detection by the hemag-
glutinin (HA) and FLAG antibodies, respectively.
Full-length mouse low-density lipoprotein receptor-related protein (LRP)9
(Sugiyama et al., 2000) was cloned into the vector pCDNA3.1 (Invitrogen) by
PCR from an American Type Culture Collection clone encoding the complete
cDNA. The HA tag was inserted after codon 28, downstream of the sequence
encoding the signal peptide as predicted by SignalP (The Center for Biological
Sequence Analysis, Technical University of Denmark, Lyngby, Denmark).
The mLRP4-LRP9 tail chimera was constructed by cloning in frame the
full-length cytoplasmic tail of LRP9 downstream of the extracellular (HA-
tagged mini receptor with ligand-binding repeat domain 4, hence mLRP4)
and transmembrane region of LRP1 (Li et al., 2000). Similarly, the LRP9-CI-
MPR tail chimera was constructed by cloning in-frame the bovine cation-
independent mannose 6-phosphate receptor (CI-MPR) tail sequence down-
stream of the complete extracellular domain and transmembrane segment of
LRP9.
GST-CI-MPR96.YA was constructed from the plasmid encoding the 163-
amino acid bovine CI-MPR tail fusion protein (Zhu et al., 2001) by inserting a
stop codon at amino acid K2403 downstream of the internal dileucine-based
sequence (ETEWLM), and mutating the YSKV sequence to ASKA, effectively
eliminating any contribution from the tyrosine-based sorting motif. GST-
YSKV was constructed by mutating E2373, upstream of the ETEWLM se-
quence, to a stop codon. GST-Nef (full-length) was kindly provided by
Warner Greene (University of California, San Francisco, CA), whereas GST-
Glut8 (1-25) was a generous gift from Kelle Moley (Washington University, St.
Louis, MO). GST-clathrin terminal domain (TD 1-579), GST-SIPWDLWEPT, the
distal amphiphysin II sequence, and GST-NECAP1 (full-length) have been
described previously (Doray and Kornfeld, 2001; Drake and Traub, 2001; Bai
et al., 2004). A GST fusion construct encoding the full-length tail of mouse
LRP9 was made by PCR from the American Type Culture Collection clone.
GST-Vamp4 (full-length) was kindly contributed by Matthew Drake (Mayo
Clinic, Rochester MN). GST-LRP9-30mer encoding the C-terminal 30 amino
Figure 1. Dileucine-based motifs bind to the  plus / subunits of AP-1 and AP-2. (A) Schematic of the subunit organization of clathrin
adaptors AP-1 and AP-2 (taken from Janvier et al., 2003) (B) cDNAs corresponding to human 1, mouse 1/1/1, and human (C)/2/
2/2 adaptins were cloned into the pFastBact-dual vectors as indicated. Recombinant bacmids isolated from E. coli DH10Bac cells were
transfected into Sf9 insect cells to generate recombinant viruses for protein expression. (C) Sequences of the various dileucine motifs used in
this study. Proteins were expressed as GST-fusions and purified from E. coli BL21 cells. (D) Silver stained gels of adaptin subunits affinity
purified from Sf9 lysates as described in Materials and Methods. Asterisk (*) indicates position of 1 adaptin. (E and F) GST pull-down assays
were performed with insect cell-expressed /1 or free  (C), and /2 or free  (D) as described in Materials and Methods.
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acids of mouse LRP9, including the proximal and distal dileucines, GST-
LRP9-p17mer (proximal 17 amino acids), GST-LRP9-d17mer (distal 17 amino
acids), GST-Vamp4-P41stop, and GST-Vamp4-S30stop were made from their
respective full-length tail fusion proteins. A list of the GST fusion proteins and
the sequences of the various dileucine-based motifs used in this study is
shown in Figure 1C. All mutant constructs were made using primers incorpo-
rating the desired mutations with the QuikChange system (Stratagene, La Jolla,
CA). All constructs and mutations were confirmed to be correct by dideoxynucle-
otide sequencing.
The anti-1 polyclonal antibody RY/1, and the anti-1 polyclonal antibody
DE/1 were kindly provided by Linton Traub (University of Pittsburgh School
of Medicine, Pittsburgh, PA). The anti-2 polyclonal antibody R11-29 was a
generous contribution of Juan Bonifacino (National Institutes of Health, Be-
thesda, MD). The anti-HA monoclonal antibody (mAb) was purchased from
Covance (Berkeley, CA), whereas the anti-FLAG tag and anti--adaptin 100/3
monoclonal antibodies were from Sigma-Aldrich (St. Louis, MO). Affinity-
purified rabbit anti-bovine CI-MPR antibody was prepared by Walter Greg-
ory in our laboratory. Glutathione-Sepharose 4B was from GE Healthcare
(Little Chalfont, Buckinghamshire, United Kingdom). All peptides were syn-
thesized by Biomolecules Midwest (Waterloo, IL). The amino acid sequences
of peptides used are as follows: ExxxLM, CADENETEWLMEEI; AxxxAA,
CADENATEWAAEEI.
Protein Expression and Purification
All GST-fusion proteins (Figure 1C) were expressed in the Escherichia coli
strain BL-21 (RIL) (Stratagene) and purified essentially as described previ-
ously (Doray and Kornfeld, 2001).
For expression in Sf9 insect cells, the various pFastBac-Dual constructs were
transformed into E. coli DH10Bac-competent cells to generate recombinant
bacmids per manufacturer’s protocol (Invitrogen). Bacmid DNAs were pre-
pared and transfected using standard protocol into Sf9 cells (Invitrogen) to
produce recombinant baculoviruses that were amplified and used to express
or coexpress the different AP-1 and AP-2 subunits in insect cells.
Immunoprecipitation of 1 and 1/1 from Sf9 cell lysates was performed
using anti-FLAG agarose, whereas immunoprecipitation of /1 was carried
out using the anti--adaptin 100/3 monoclocal antibody with protein G-
Sepharose. Washed beads were competitively eluted with either the FLAG
peptide or the 100/3 epitope peptide. Eluted proteins were resolved by
SDS-polyacrylamide gel electrophoresis (PAGE), and the protein band was
visualized using the Silver Stain Plus kit (Bio-Rad, Hercules, CA).
Binding Assays
GST pull-down assays were performed essentially as described previously
(Doray and Kornfeld, 2001). For insect cell-expressed proteins, typically 100–
150 l of total cell lysates (5–10 mg/ml) was used for each GST pull-down
assay. Peptide competition experiments were performed in the same manner
except that the indicated peptides were added to a final concentration of 200
M from a buffered stock solution. Typically, 20% of pellet fractions and 3%
of unbound fractions were analyzed by SDS-PAGE and Western blotting.
Nitrocellulose membranes were routinely stained with Ponceau solution to
ascertain equal loadings of fusion proteins.
Cell Culture and Transfection
The LRP1-null Chinese hamster ovary (CHO) cells were cultured in Ham’s
F-12 medium as described previously (FitzGerald et al., 1995). Transient
transfection into LRP-null CHO cells was achieved by transfection of 1 g of
plasmid DNA in 12-well plates by using the Mirus Trans-IT CHO kit accord-
ing to the manufacture’s instructions (Mirus, Madison, WI). Microscopy, cell
surface biotinylation, and endocytosis assays were generally performed 24 h
posttransfection.
Immunofluorescence and Confocal Microscopy
CHO cells on glass coverslips transiently expressing wild-type HA-LRP9, or
the mutants were fixed in 3.7% formaldehyde in phosphate-buffered saline
(PBS), washed with PBS, and blocked and permeabilized with 0.4% Triton
X-100, 2% IgG-free bovine serum albumin (BSA) (Jackson ImmunoResearch
Laboratories, West Grove, PA) in PBS. Anti-HA mouse mAb (1:1000 dilution)
or anti-CI-MPR rabbit polyclonal antibody (1:1000 dilution) were applied in
antibody dilution buffer (0.1% Triton X-100, 0.5% IgG-free BSA in PBS). After
washing with PBS, secondary antibodies Alexa 488-anti-mouse and Alexa
568-anti-rabbit (Invitrogen) were applied in antibody dilution buffer. The
coverslips were washed and mounted on slides with mounting medium
(Biomeda, Foster City, CA). Images were obtained with a Fluoview 500
confocal microscope (Olympus, Tokyo, Japan).
Cell Surface Biotinylation
Cell surface biotinylation experiments were performed using the EZ-Link
Sulfo-NHS-LC Biotin reagent (Pierce Chemical, Rockford, IL). Transfected
cells were washed three times with ice-cold PBS 1 mM calcium chloride and
0.5 mM magnesium chloride (PBSc), and 1 ml of the cell-impermeable biotin
solution (2 mg/ml) in PBSc was added to each well. Cells were incubated on
ice with gentle agitation for 15 min and then washed once with cold 50 mM
Tris, pH 8, to quench the reaction, followed by three washes with PBSc. Cells
were lysed in 250 l/well PBS  1% Triton-X-100, 1X complete protease
inhibitor cocktail (Roche Diagnostics, Indianapolis, IN), and 1 mM phenyl-
methylsulfonyl fluoride with rocking at 4°C for 30 min. An aliquot of the
postnuclear supernatant was reserved, and the remaining lysate was com-
bined with PBSc and 50 l of streptavidin-agarose beads in a total volume of
1 ml. After an overnight incubation of the beads and lysate at 4°C with
tumbling, the beads were washed 4 times with ice-cold PBSc and resuspended
in reducing sample buffer. One percent of the lysates and 5% of the pull-down
products were run on 8% SDS-PAGE and transferred to nitrocellulose mem-
branes, followed by Western blot with anti-HA.
Kinetic Analysis of Endocytosis
Kinetic analysis of endocytosis was performed essentially as described pre-
viously (Li et al., 2000) except iodinated anti-HA IgG was used as ligand
instead of iodinated receptor-associated protein, and PBS, pH 2.0, was used to
strip antibody from the cell surface. The sum of ligand that was internalized
plus that which remained on the cell surface after each assay was used as the
maximum potential internalization. The fraction of internalized ligand after
each time point was calculated and plotted.
RESULTS
Dileucine-based Motifs Bind Selectively to the /1 and
/2 Hemicomplexes of AP-1 and AP-2
In our initial experiments, we used the GST pull-down tech-
nique to examine the binding of individual subunits of AP-1
and AP-2 as well as the /1, 1/1, /2, and 2/2
hemicomplexes to dileucine-based motifs. The various sub-
units were expressed in Sf9 insect cells with the hemicom-
plexes being coexpressed from a bicistronic vector. Cell ly-
sates served as the source of the proteins. The / and
1/2 subunits were tagged with HA and FLAG epitopes,
respectively, to facilitate detection. To rule out the possibil-
ity that the overexpressed mammalian adaptin subunits
were coassembling with the orthologous subunits of Sf9
cells, affinity-purified 1, 1/1, and /1 were analyzed
by silver staining of SDS gels. As shown in Figure 1D, the
presence of 1 adaptin was only evident in the 1/1 lane,
indicating that the individually expressed 1 subunit was
unable to form a hemicomplex with the insect cell 1 sub-
unit. The lack of 1 in the purified /1 lane likewise
indicates that this hemicomplex is unable to form a het-
erotetramer with the endogenous 1/1 hemicomplex of
Sf9 cells.
As ligands, we used GST peptide fusions (or the full-
length protein in the case of NEF) encoding dileucine motifs
derived from various proteins as shown in Figure 1C. We
initially tested the binding by /1 and /2 hemicom-
plexes as well as free  and  subunits to GST-LRP9-30mer,
which contains two acidic dileucine motifs, each of which
mediates rapid endocytosis (Knisely and Kornfeld, unpub-
lished data). As shown in Figure 1, E and F, both hemicom-
plexes bound well to the GST-LRP9 dileucine-based motifs,
whereas only trace binding occurred with the individual 
and  subunits. However, the free  and  subunits bound
robustly to GST-amphiphysin and GST-NECAP1, respectively.
This binding, previously shown to be mediated by the interac-
tion of the appendage domains of  and  to WXXF/W motifs
present in these proteins (Drake and Traub, 2001; Ritter et al.,
2003) indicates that the  and  subunit appendage domains
had folded properly in the insect cells. When 1 was expressed
individually in the Sf9 cells, the yield was very poor compared
with /1 coexpression and the protein that was recovered was
almost completely in a high-molecular-weight aggregate.
This prevented us from testing the 1 subunit directly in the
pull-down assays.
We next tested the ability of the /1 and /2 hemicom-
plexes to bind to a panel of dileucine-based motifs derived
/1 and /2 Hemicomplexes
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from proteins where these motifs have been implicated in
AP-1 and/or AP-2 binding. As shown in Figure 2, A and B,
both hemicomplexes bound to each of the dileucine-based
motifs, although there were differences in the degree of the
binding. Thus, the /1 hemicomplex bound the Vamp4
dileucine-based motif much better than it bound the NEF
motif, whereas the opposite occurred in the case of /2.
The basis for these differences and the implication for pro-
tein trafficking are explored in more detail in a later section
of this article under the subheading Roles of the Residues
Adjacent to the Position 0 Leucine in Hemicomplex Binding.
Although the /1 hemicomplex bound to multiple
dileucine-based motifs, it exhibited no binding to a typical
Y-based motif (Figure 2C). We consistently observed that the
/2 hemicomplex displayed a low level of binding above
background levels for the CI-MPR Y-based motif in our
pull-down assays, but this binding was significantly weaker
relative to the dileucine-based motif (Figure 2C).
In contrast to the findings with the /1 and /2 hemi-
complexes, the 1/1 and 2/2 hemicomplexes as well as
the individual  and  subunits exhibited either undetect-
able binding to the panel of GST-dileucine–based motifs or
trace binding that could at times only be detected after
prolonged exposure of the blots (Figure 2, D–F). As a posi-
tive control, both / hemicomplexes as well as the indi-
vidual  subunits bound well to the YSKV motif of the
CI-MPR. This motif has been shown to be important for the
interaction of the CI-MPR tail with cytosolic AP-1 (Ghosh
and Kornfeld, 2004) and for internalization of the receptor
from the cell surface (Jadot et al., 1992), presumably through
its association with the  subunits of AP-1 and AP-2. There
was no binding above background level of the isolated 
subunits to the GST-YSKV (data not shown), indicating that
the / hemicomplexes bound via their  subunits. The 
subunits, instead, bound well to the GST-clathrin TD as
expected (Shih et al., 1995), demonstrating that the peptide
sequences in the hinge of the  subunits responsible for
binding to the terminal domain were exposed. Mutations of
the dileucine sequences to dialanine in both GST-CIMPR-
96.YA and GST-LRP9-d17mer abolished binding by the
/1 hemicomplex, indicating the specificity of the interac-
tion (Figure 3, A and B). Similar results were obtained with
the /2 hemicomplex (Figure 3, B and C).
Together, these results clearly demonstrate that the /1
and /2 hemicomplexes bind well to dileucine-based mo-
tifs, whereas the 1/1 and 2/2 hemicomplexes as well
as the individual , , , and  subunits bind poorly, or not
at all, to these motifs.
The Appendage and Hinge Regions of  and  Are Not
Required for Hemicomplex Binding to Dileucine-based
Signals
The crystal structure of the AP-1 core reveals that the 1
subunit interacts with the N-terminal half of the  subunit
Figure 2. Dileucine-based motifs bind selectively to the /1 and the /2 hemicomplex. (A–F) The different subunits of AP-1 and AP-2
were tested for their ability to bind to a panel of dileucine-based motifs derived from the indicated proteins. GST-clathrin TD and GST-YSKV
served as positive controls in the binding assays for the  and  subunits, respectively. Binding assays were performed as described in
Materials and Methods, and Western blots were probed with the indicated antibodies. 1* indicates a 5X longer exposure of the 1 blot.
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(Heldwein et al., 2004). Furthermore, it has been reported
that the /1 hemicomplex does not require the hinge and
appendage domains of  for interacting with dileucine-
based motifs (Janvier et al., 2003). However, in that study, the
595 amino acid trunk domain was left intact. By expressing a
series of /1 hemicomplexes with progressive deletions from
the C-terminal portion of  trunk, we have determined that the
N-terminal 341 amino acids of the  trunk are sufficient to form
a competent dileucine-binding hemicomplex with 1 (Figure 4,
A and B). This constitutes the portion of the trunk that interacts
with the 1 subunit (Heldwein et al., 2004). This result is also in
agreement with the findings of Page and Robinson (1995),
showing that the N-terminal 331 amino acids of the  trunk are
sufficient to target a - chimeric protein to the TGN. Our own
observation that the  subunit is incapable of forming a com-
petent dileucine-binding hemicomplex with the 2 subunit in
Sf9 cells (data not shown), together with the results of previous
yeast two- and three-hybrid studies (Page and Robinson, 1995;
Janvier et al., 2003), indicate that the ability of either the  or 
subunit to form a hemicomplex with its cognate  adaptin
subunit is critical for both proper targeting (TGN or plasma
membrane) and binding to sorting signals.
In our pull-down experiment, we also examined the effect
of a soluble 14-amino acid peptide containing the dileucine
motif of the CI-MPR (ETEWLM) on the binding of the
truncated /1 hemicomplex to two GST-fusions. A peptide
with the same sequence except for E 3 A and LM 3 AA
substitutions was used a control. As shown in Figure 4B, the
wild-type peptide, at 200 M, strongly inhibited binding to
both GST-fusion proteins, whereas the mutant peptide at the
same concentration was without effect. These findings pro-
vide additional evidence that the /1 hemicomplex is ac-
tually binding to dileucine-based motifs.
We also prepared a /2 hemicomplex with the  subunit
truncated at residue 623, resulting in loss of the hinge and
appendage domains of that subunit. Figure 4C, shows that
this mutant hemicomplex bound well to the GST-LRP9-
30mer, whereas the truncated  subunit by itself exhibited
only trace binding over the GST control. Thus, the hinge and
appendage of the  subunit is not required for binding of the
/2 hemicomplex to dileucine-based motifs.
Role of the Residues Adjacent to the Position 0 Leucine in
Hemicomplex Binding
During the course of these experiments, we noted several
instances where individual dileucine-based motifs bound
differently to the /1 and /2 hemicomplexes. An exam-
ple of this involving the binding of the Vamp4 and NEF
motifs was pointed out in an earlier section of the article
under the subheading Dileucine-based Motifs Bind Selectively
to the /1 and /2 Hemicomplexes of AP-1 and AP-2 (Figure
2, A and B). Another instance concerns the proximal (EDD-
VLL) and distal (EDEPLL) dileucine-based motifs of LRP9.
The /2 hemicomplex bound both motifs well, whereas
the /1 hemicomplex only bound well to the distal motif
(Figure 5A). An alignment of these sequences shows only
two amino acid differences, at the 1 and 2 positions.
Hence, we mutated the aspartate and valine of the proximal
motif, either individually or together, to glutamate and pro-
line, respectively, to see whether binding to the /1 hemi-
complex could be achieved. As shown in Figure 5B, the
individual substitution of the aspartate to glutamate at po-
sition 2 had a modest impact on /1 binding, whereas
the valine-to-proline substitution at position 1 had only a
very small effect. However, when the two residues were
simultaneously mutated, strong binding was achieved,
equivalent to that obtained with the distal dileucine-based
motif. These results demonstrate that amino acids immedi-
ately upstream of the dileucine sequence can significantly
impact the specificity of the interaction with different hemi-
complexes.
In contrast to the dileucine-based motifs of LRP9, both of
which bind well to the /2 hemicomplex, the internal
dileucine motif of the CI-MPR (ETEWLM) binds better to the
/1 hemicomplex than to the /2 hemicomplex (Figure
5C). Mutation of the1 residue from W to P, as occurs in the
LRP9 distal dileucine motif, had no substantial impact on
binding (Figure 5C). However, when the LM sequence was
changed to LL, there was a major increase in binding by the
/2 hemicomplex (Figure 5C) with no alteration in binding
by /1. This indicates that the two hemicomplexes differ in
their preference for the 1 residue.
We have reported that rapid internalization of the CI-MPR
is dependent on the tyrosine-based YSKV motif in the cyto-
solic tail of the protein (Jadot et al., 1992). Because the mutant
CI-MPR tail internal dileucine-based sequence (LM 3 LL)
bound the /2 hemicomplex much better than did the
native sequence, we asked whether this mutant sequence
could compensate for the tyrosine mutation in the context of
the LRP9-CI-MPR tail chimeric fusion in the in vivo setting.
To answer this question, we performed cell surface biotiny-
lation experiments on cells transfected with the chimera
containing either the wild-type CI-MPR tail, the YSKV 3
ASKA mutation, or the YSKV 3 ASKA and ETEWLM 3
ETEPLL double mutation. The results presented in Figure
Figure 3. Mutation of dileucine sequence to dialanine abolishes
hemicomplex binding. (A–C) The specificity of the interaction of the
/1 and /2 hemicomplexes for either the CI-MPR internal
dileucine-based sequence or the LRP9 distal dileucine-based se-
quence was tested by mutation of the CI-MPR ETEWLM sequence
to ATEWAA and the LRP9-d17mer EDEPLL sequence to EDEPAA.
/1 and /2 Hemicomplexes
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5D show that the tyrosine mutation, as expected, strikingly
increased the level of chimeric protein on the cell surface.
The ETEWLM3 ETEPLL mutation, which significantly en-
hanced binding of the /2 hemicomplex in our in vitro
binding assays, reversed the effect of the tyrosine mutation,
indicating that improved binding to the /2 hemicomplex
is recapitulated in in vivo trafficking events.
Role of the Residue at the 4 Position of Dileucine-based
Motifs
Aside from a few exceptions, the dileucine-based motifs
reported to date have either a glutamate or aspartate at the
4 position (Bonifacino and Traub, 2003). Because all the
dileucine sequences tested thus far in this study had a glu-
tamate residue at that position, we asked whether interac-
tion with the two different hemicomplexes would be per-
turbed by substituting the relevant glutamate for either an
aspartate, alanine, or arginine. We initially substituted the
4 glutamate in GST-CIMPR-96.YA and determined the
effect on /1 and /2 hemicomplex binding in GST pull-
down assays. As shown in Figure 6A, the E3A substitution
greatly decreased the binding of both hemicomplexes, as
expected. Surprisingly, the E 3 D substitution almost com-
pletely abrogated binding by the /1 hemicomplex,
whereas only having a modest effect on /2 binding. Mu-
tation of the 4 glutamate of the Vamp4 dileucine motif to
an aspartate also led to loss of /1 binding (Figure 6A).
Similarly, the E 3 D substitution of the GST-LRP9-d17mer
construct resulted in a significant loss of binding by the /1
hemicomplex with only a minimal effect on /2 binding
(Figure 6B). An E 3 R mutation at the 4 position of
GST-LRP9d17mer resulted in complete loss of binding by
both /1 and /2, indicating that a basic residue cannot
be tolerated at this position for hemicomplex binding (Fig-
ure 6B).
To validate that the pull-down assays correlated with in vivo
protein trafficking, we examined the consequence of the LL3
AA and E3 D substitutions on the distribution and internal-
ization of either LRP9 or the mLRP4-LRP9 chimera, respec-
tively, transfected into LRP1-null CHO cells. The latter is presum-
ably a measure of interaction with AP-2. The LRP9 cytosolic tails
used in these experiments had the proximal dileucine-based motif
mutated, so that its trafficking was solely dependent on the distal
dileucine sequence (Knisely and Kornfeld, unpublished data).
Similar to wild-type LRP9 (data not shown), this protein was
predominantly localized to intracellular vesicles that had sub-
stantial overlap with the CI-MPR (Figure 7A). When the distal
dileucines were changed to alanines, the mutant protein accu-
mulated on the cell surface, confirming that its internalization
was dependent on the distal dileucine-based motif (Figure 7B).
Like the LL3AA mutation, the4 E3 R substitution within
the distal dileucine-based sequence also resulted in a predom-
inantly cell surface distribution (data not shown), indicating
that substitution of a basic amino acid for the acidic residue at
this position is detrimental to the internalization of LRP9. A
similar observation has been made with the glutamate to argi-
Figure 4. Hemicomplex binding to dileucine-based motifs does not require the appendage and hinge regions of AP-1 and AP-2. (A) The
N-terminal 341 amino acids of  trunk are sufficient to form a hemicomplex with 1. (B) Competition experiments with the 341/1
hemicomplex were performed with either wild-type (ETEWLM) or mutant (ATEWAA) soluble peptides at 200 M concentration as described
in Materials and Methods. (C)  Adaptin(1-623) was expressed in Sf9 cells with or without the 2 and tested for its ability to bind the LRP9
dileucine-based motifs by using the GST pull-down assay.
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nine mutation within the LIMPII dileucine-based sequence
(Sandoval et al., 2000). In contrast, LRP9 with an E 3 D sub-
stitution at the 4 position achieved a distribution indistin-
guishable from the protein with the wild-type sequence (Figure
7C), consistent with the substitution having only a minor effect
on the interaction with AP-2 (Figure 6B). As a complement to
these morphological assays, we performed kinetic studies to
determine the rate of internalization of these constructs. In
these assays, we used mLRP4-LRP9 chimeras consisting of the
extracellular (ligand-binding repeat domain 4) and transmem-
brane domains of LRP1 fused to the cytoplasmic tail of LRP9.
Iodinated antibodies against the HA epitope within the mLRP4
domain on the cell surface were bound at 4°C, and after warm-
ing the cells to 37°C, the rate of internalization of the antibody
followed for 10 min (Figure 7D). These assays showed that the
E 3 D substitution had no effect on the rate of endocytosis,
whereas the LL 3 AA mutation abolished rapid internaliza-
tion. Together, these studies establish an excellent correlation
between the pull-down assays involving the /2 hemicom-
plex and the in vivo behavior of the protein in AP-2–mediated
processes. Unfortunately, there are no assays available at this
time that would allow us to determine in a selective manner
the interaction of the various dileucine-based motifs with AP-1
in intact cells.
DISCUSSION
The data presented in this study provide strong evidence
that it is the /1 and /2 hemicomplexes of AP-1 and
AP-2, respectively, rather than the / hemicomplexes that
bind dileucine-based motifs. The findings with the /1
hemicomplex confirm the results obtained with the yeast
three-hybrid assay (Janvier et al., 2003; Coleman et al., 2005,
2006; Theos et al., 2005). However, that assay failed to detect
any interaction between dileucine motifs and the /2
hemicomplex, leaving unresolved the question of how AP-2
binds dileucine-based motifs. The results of our binding
experiments with the individual subunits and hemicomplex
Figure 5. Residues adjacent to the leucine at position 0 can dictate avidity and specificity of hemicomplex binding to particular dileucine-
based motifs. (A) The ability of the /1 and /2 hemicomplexes to bind to the LRP9 distal and proximal dileucine-based motifs was
assessed by GST pull-down assays performed simultaneously. (B) Mutations of residues at the 1 and 2 positions were introduced singly
or together within the LRP9 proximal dileucine-based sequence to see whether binding of the /1 hemicomplex could be achieved. (C)
Substitutions within the CI-MPR internal dileucine-based sequence were assessed for changes in avidity for the / 1or /2 hemicomplex
binding by using the GST pull-down assay. (D) Cell surface biotinylation was performed to test the ability of the altered CI-MPR
dileucine-based sequence (ETEWLM 3 ETEPLL) to rescue the tyrosine mutation as described in Materials and Methods.
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forms of AP-1 and AP-1 expressed in Sf9 insect cells estab-
lish that both AP-1 andAP-2 recognize dileucine-based mo-
tifs via a similar mechanism. Furthermore, our demonstra-
tion that the exogenously expressed mammalian adaptin
subunits do not associate with endogenous insect cell
adaptins gives us confidence that the sorting signal–adaptin
interactions we report in this study are highly specific for the
adaptin subunits in question (Figure 1D).
In our experiments the / hemicomplexes as well as the
individual  subunits exhibited good binding to a known
tyrosine-based signal (YSKV of the CI-MPR), but they failed
to display appreciable binding to any of the dileucine-based
sequences tested in the GST pull-down assays. This is in
contrast to previous studies showing either the  subunit
(Greenberg et al., 1998; Rapoport et al., 1998; Geyer et al.,
2002; Schmidt et al., 2006) or the  subunit (Rodionov and
Bakke, 1998; Hofmann et al., 1999; Craig et al., 2000; Rodionov et al.,
2002; Hinners et al., 2003) as being the AP complex subunit
responsible for recognition of dileucine-based sorting mo-
tifs. In our experiments with the free  and  subunits, we
did detect very low levels of binding to selected dileucine-
based motifs upon longer exposure of the blots (Figure 2, E
and F). Perhaps these weak interactions may account for the
results obtained in the previous yeast two-hybrid and sur-
face plasmon resonance studies, because these assays are
more sensitive than the GST pull-down technique. Never-
theless, because our assays tested all four hemicomplexes as
well as the individual subunits (with the exception of 1 and
2) in side-by-side comparisons, we believe that our find-
ings strongly favor the conclusion that it is the /1 and
/2 hemicomplexes that mediate binding of dileucine-
based motifs, whereas the  subunits bind tyrosine-based
motifs.
Although both the /1 and /2 hemicomplexes bound
dileucine-based motifs, they exhibited considerable differ-
ences in their preferences for the various sequences that
were tested. Based on numerous reports in the literature,
most of which deal with the function of dileucine-based
motifs in endocytosis, a general sequence of 4D/
E3X2X1X0L1[LMI] has been defined (Bonifacino and
Traub, 2003). Our data show that residues upstream and
downstream of the leucine at position 0 can selectively in-
fluence binding to the AP-1 /1 and AP-2 /2 hemicom-
plexes. The most striking example of this was seen when we
compared the effect of having an aspartate as opposed to a
glutamate at the 4 position. Both hemicomplexes bound
well when a glutamate was present, but an aspartate at this
position severely compromised binding by the /1 hemi-
complex, whereas only having a modest effect on /2
hemicomplex binding. This result was obtained with three
dileucine motifs that differed in the residues in the 1 to 3
positions (Figure 6). In agreement with the lack of effect on
/2 hemicomplex binding, the E3 D mutation at position
4 did not alter the rate of endocytosis or cellular distribu-
tion of LRP9 (Figure 7, A and B). Unfortunately, the lack of
an in vivo assay system that is specific for AP-1 precluded us
from testing the effect of this mutation in the in vivo setting.
Nonetheless, these findings demonstrate that /1, unlike
/2, is much less tolerant of an aspartate in the 4 position
compared with a glutamate in the same position. This ob-
servation may provide an explanation for why the DKQTLL
sequence of CD3- failed to bind to /1 in the yeast three-
hybrid assay, unlike the other dileucine-based sequences
that were tested, all of which had a glutamate at the 4
position (Coleman et al., 2005). Our results also suggest, as
has been alluded to previously (Rodionov et al., 2002), that
the /2 hemicomplex of AP-2 may display a broader spec-
ificity in terms of recognizing dileucine-based motifs to en-
sure the efficient internalization of proteins that missort to
the cell surface.
The LRP9 proximal and distal dileucine-based sequences
illustrate how specificity of hemicomplex binding is influ-
enced by residues in the 1 and 2 positions. These two
sequences are identical except for the residues at these two
positions (Figure 1C). In this case, the /1 hemicomplex
binds only the distal sequence, whereas the /2 hemicom-
plex binds both sequences equally well (Figure 5, A and B),
in agreement with our finding that either sequence can
function efficiently in endocytosis (Knisely and Kornfeld,
unpublished data).
Figure 6. An aspartate cannot substitute for the 4 glutamate for
/1 binding but can do so for /2 binding. (A–C) GST pull-down
assays were performed with either the wild-type dileucine-based
motifs of CI-MPR, Vamp4, and LRP9, or the 4 glutamate of these
sequences mutated to an alanine or an aspartate (A and B), or an
arginine (C). Binding assays were performed with the /1 and
/2 hemicomplexes as described in Materials and Methods.
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An example of the role of the residue at position 1 in
determining specificity for the hemicomplexes is illustrated
by our mutagenesis study whereby a single substitution
within the CI-MPR internal dileucine-based sequence
(ETEWLM 3 ETEWLL) resulted in a significant increase in
binding of the /2 hemicomplex to the altered sequence
(Figure 5C). That this change in hemicomplex binding in
vitro is physiologically relevant in vivo is shown by the
ability of the altered dileucine sequence, but not the original
sequence, to compensate for the tyrosine mutation in the
CI-MPR tail in internalization (Figure 5D). This process is
presumably mediated by AP-2.
Together, these results show that the interaction of any
particular D/EXXXL[LMI] sequence with either the AP-1
/1 or the AP-2 /2 hemicomplex will be dictated by the
nature of the amino acids at the 1 to 4 positions, and the
1 position. The nature of these residues can determine
whether a functional interaction will occur at the various
sorting stations within the cell. Interestingly, Bakke and
colleagues have made similar observations, although their
reported interactions of the dileucine-based sequences were
with the  subunits of AP-1 and AP-2 (Hofmann et al., 1999;
Rodionov et al., 2002).
Although our results establish that both the /1 and
/2 hemicomplexes bind well to dileucine-based motifs,
the question remains as to precisely how these motifs en-
gage the hemicomplexes. The studies using various trunca-
tions of the  subunit revealed that the N-terminal 341
amino acids of , representing the amino half of the trunk
domain, when coexpressed with 1, are sufficient to form a
hemicomplex that binds dileucine-based motifs just as well
as the complex containing the full-length  subunit. This
finding localizes the binding site to this region of the /1
hemicomplex. The  and  subunits by themselves exhibited
only trace binding to the dileucine-based motifs. These sub-
units bound strongly to WXXW/F motifs that are known to
interact with the appendage domains of the protein, show-
ing that the appendages had folded correctly in the insect
cells. However, this does not prove that the trunk domains
had also folded properly, leaving open the possibility that
dileucine-based motifs interact with elements of the N-ter-
minal half of the  trunk. Unfortunately, the 1 subunit,
when expressed alone, formed an insoluble aggregate that
prevented us from testing this subunit for its ability to bind
the dileucine-based motifs. This suggests that the 1 subunit
requires the N-terminal region of  to fold correctly, consis-
Figure 7. /2 binding to the variant LRP9
distal dileucine-based sequences correlates
strongly with in vivo internalization mediated
by these sequences. (A) The subcellular distri-
bution of transiently expressing LRP9 (green)
with the proximal dileucine-based motif mu-
tated was analyzed along with endogenous
CI-MPR (red) in CHO cells. Colocalization
(yellow) is observed by merging the green and
red signals. The distribution of the distal LL3
AA and 4 E 3 D mutants in the context of
the LRP9 proximal LL 3 AA construct is
shown in B and C, respectively. (D) Kinetic
analysis of endocytosis of the mLRP4-LRP9
tail constructs was performed as described in
Materials and Methods. The mLRP4 tail-less
construct served as the negative control in
these assays.
/1 and /2 Hemicomplexes
Vol. 18, May 2007 1895
tent with the reported structure of the AP-1 core, which
revealed that 1 interacts with this portion of the  subunit
(Heldwein et al., 2004). At this point, three models could
explain our findings. The binding pocket for dileucine-based
motifs could either reside on the  subunits or the trunk
regions of the  and  subunits, or they could be formed by
elements derived from both the  subunits and the N-ter-
minal trunk regions of  and  that interact with . Efforts to
characterize the precise binding site for dileucine-based mo-
tifs within the /1 hemicomplex are currently underway in
our laboratory. Nevertheless, we think that the experimental
evidence presented in this study establish that the  sub-
units with their cognate partners comprise the bona fide
dileucine binding sites of the AP-1 and AP-2 complexes.
While this article was under revision, it was reported by
Bonifacino and colleagues (Chaudhuri et al., 2007; published
online ahead of print on Jan. 31, 2007, in the Journal of
Virology) that the Nef EXXXLL motif binds to the /2
hemicomplex, in agreement with our data.
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